Association between serum per- and polyfluoroalkyl substances levels and metabolic dysfunction-associated steatotic liver disease
Environmental Pollution · 2024-12 · 363 · 125233
DOI: 10.1016/j.envpol.2024.125233 ↗Kurz gefasst
Fachartikel in der Zeitschrift Environmental Pollution, 2024-12. Verfasst von Jin Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Occupational and Environmental Health, Ministry of Education Key Laboratory of Environment and Health, and State Key Laboratory of Envi…. Hauptthemen laut MEDLINE: Fluorocarbons, Fatty Liver, Environmental Pollutants. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
Experimental evidences have suggested that Per- and polyfluoroalkyl substances (PFASs) were hepatotoxicity, but epidemiologic inconsistencies. There were 1751 participants included in this study after excluding chronic hepatitis, cirrhosis, excessive alcohol drinkers, and those with missing key variables. Totally 30 PFASs were quantified using ultrahigh-pressure liquid chromatography tandem mass spectrometer (UPLC-MS). Metabolic dysfunction-associated steatotic liver disease (MASLD) defined as the presence of hepatic steatosis diagnosed on abdominal B-ultrasound in conjunction with at least one cardiometabolic risk factors (CMRF) and without other discernible cause. After multivariate adjustment, perfluorooctanoic acid (PFOA), perfluorononanoic acid (PFNA), perfluoroalkyl carboxylates (ΣPFCAs), and perfluoroheptanoic acid (PFHpA) were positively associated with the risk of MASLD. Specifically, for each natural log-transformed unit increase in PFOA, PFNA, and ΣPFCAs, the risk of MASLD increased by 27% (95% confidence interval (CI): 1.09-1.48), 10% (95% CI: 0.99-1.23), and 29% (95% CI: 1.09-1.53), respectively. Compared with those in Tertile 1 of PFOA, PFNA, and ΣPFCAs, the risk of MASLD was increased by 35% (95% CI: 1.06-1.71, Ptrend = 0.019), 46% (95% CI: 1.15-1.85, Ptrend = 0.0018), and 43% (95% CI: 1.13-1.82, Ptrend = 0.0032) in Tertile 3, respectively. For PFHpA (detection rate: 14.79%), individuals with PFHpA levels above the detection limit had increased risk of MASLD by 54% (95% CI: 1.17-2.01) compared with those with PFHpA levels below the detection limit. While 8:2 chlorinated polyfluoroethersulfonic acid (8:2 Cl-PFESA) was inversely associated with steatotic liver disease (SLD) combined with 4 or 5 CMRFs (odds ratio per ln-unit = 0.87, 95% CI: 0.77-0.99). Mixed exposure analysis showed PFNA manifested a significant positive effect, while PFUdA had a significant negative effect. No association was found between other PFASs and MASLD prevalence. More prospective studies are needed to validate our conclusions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Occupational and Environmental Health, Ministry of Education Key Laboratory of Environment and Health, and State Key Laboratory of Environmental Health (Incubating), School of Public Health, Tongji Medical…
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Zhang, J., Cheng, X., Wang, Y., Guo, H., Liu, L., Liu, L., Gao, J., & He, M. (2024). Association between serum per- and polyfluoroalkyl substances levels and metabolic dysfunction-associated steatotic liver disease. Environmental Pollution, 363, 125233. https://doi.org/10.1016/j.envpol.2024.125233
Vancouver
Zhang J, Cheng X, Wang Y, Guo H, Liu L, Liu L, et al. Association between serum per- and polyfluoroalkyl substances levels and metabolic dysfunction-associated steatotic liver disease. Environmental Pollution. 2024;363:125233. doi:10.1016/j.envpol.2024.125233
BibTeX
@article{Zhang2024,
author = {Zhang, Jin and Cheng, Xu and Wang, Yu and Guo, Hong and Liu, Lin and Liu, Lu and Gao, Junya and He, Meian},
title = {Association between serum per- and polyfluoroalkyl substances levels and metabolic dysfunction-associated steatotic liver disease},
journal = {Environmental Pollution},
year = {2024},
volume = {363},
pages = {125233},
doi = {10.1016/j.envpol.2024.125233}
}
EUVIMED